(0.51%) 5 214.08 points
(0.85%) 39 388 points
(0.27%) 16 346 points
(0.47%) $79.63
(0.39%) $2.31
(0.52%) $2 352.50
(0.76%) $28.58
(0.26%) $993.40
(-0.31%) $0.927
(-0.39%) $10.85
(-0.25%) $0.798
(0.84%) $92.51
5 days till quarter result
(bmo 2024-05-14)
Expected move: +/- 9.96%
@ $15.49
Išleistas: 14 vas. 2024 @ 22:23
Grąža: -6.07%
Ankstesnis signalas: vas. 14 - 19:00
Ankstesnis signalas:
Grąža: 1.51 %
Live Chart Being Loaded With Signals
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role...
Stats | |
---|---|
Šios dienos apimtis | 580 754 |
Vidutinė apimtis | 840 057 |
Rinkos kapitalizacija | 1.16B |
EPS | $0 ( 2024-05-07 ) |
Kita pelno data | ( $-0.510 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.31 |
ATR14 | $0.0190 (0.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-09 | Peng Katie | Buy | 35 767 | Stock Option (Right to Buy) |
2024-04-09 | Peng Katie | Buy | 26 825 | Common Stock |
2024-02-16 | Myles Edward H | Sell | 4 744 | Common Stock |
2024-02-16 | Qatanani Mo | Sell | 2 512 | Common Stock |
2024-02-16 | Parlavecchio Caryn | Sell | 3 751 | Common Stock |
INSIDER POWER |
---|
57.30 |
Last 96 transactions |
Buy: 9 442 259 | Sell: 2 434 527 |
Tūris Koreliacija
Scholar Rock Holding Corp Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
FOX | 0.897 |
FOXA | 0.891 |
CRTO | 0.889 |
GOODM | 0.882 |
BPRN | 0.882 |
IMAB | 0.872 |
DSKE | 0.872 |
CIGI | 0.867 |
CVCY | 0.86 |
CINF | 0.86 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
NESR | -0.841 |
IMPP | -0.83 |
SFBC | -0.818 |
SGII | -0.812 |
FRG | -0.812 |
HBANO | -0.812 |
MRM | -0.809 |
ARCE | -0.807 |
PTMN | -0.802 |
EGLE | -0.801 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Scholar Rock Holding Corp Koreliacija - Valiuta/Žaliavos
Scholar Rock Holding Corp Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $0 |
Bruto pelnas: | $-2.84M (0.00 %) |
EPS: | $-1.990 |
FY | 2023 |
Pajamos: | $0 |
Bruto pelnas: | $-2.84M (0.00 %) |
EPS: | $-1.990 |
FY | 2022 |
Pajamos: | $33.19M |
Bruto pelnas: | $23.31M (70.22 %) |
EPS: | $-2.21 |
FY | 2021 |
Pajamos: | $18.82M |
Bruto pelnas: | $0.00 (0.00 %) |
EPS: | $-3.59 |
Financial Reports:
No articles found.
Scholar Rock Holding Corp
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients suffering from a range of serious diseases, including neuromuscular disorders, cancer, and fibrosis. The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.